Wyeth labs in NJ to close

    As part of Pfizer’s takeover of Wyeth, research facilities around the country will be trimmed or closed.

    As part of Pfizer’s takeover of Wyeth, research facilities around the country will be trimmed or closed.

    Pfizer announced it will close six research labs, including South Brunswick, NJ, and reduce the work at others, including Collegeville in Montgomery County. Some employees will shift to the new company’s main research facilities in Massachusetts, Connecticut, New York, California or the United Kingdom. Others will be laid off, as part of the company’s 20,000-job reduction.

    In a press release, Martin Mackay, the president of PharmaTherapeutics Research and Development at Pfizer said, “Moving forward on our aggressive timeline, we are analyzing the combined portfolio and prioritizing research projects that will address unmet medical need and bring Pfizer’s scientific and competitive advantage to the benefit of patients.”

    The Star-Ledger reported that most of the 450 employees in South Brunswick, NJ, who worked on developing Alzheimer’s drugs, will be laid off.

    Wyeth’s Collegeville campus, which is now Pfizer’s headquarters for specialty medicine, will remain open.

    Want a digest of WHYY’s programs, events & stories? Sign up for our weekly newsletter.

    It will take 126,000 members this year for great news and programs to thrive. Help us get to 100% of the goal.